CG Oncology (CGON) Research & Development (2023 - 2026)
CG Oncology's Research & Development was $54.66 million in Q2 2026, up 74.5% from $31.33 million a year earlier and up 25.0% from the prior quarter.
Powered by 
Analysis
CG Oncology (CGON) Research & Development (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, CG Oncology's Research & Development was $156.23 million through Jun 30, 2026, up 48.5% year-over-year; for FY2025, it came in at $116.64 million, up 42.1% from FY2024.
- In earlier years, Research & Development was $82.1 million in FY2024 (+79.5%) and $45.75 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Research & Development in data going back to Q1 2023.
- Compared with a year earlier, Research & Development has increased for ten straight quarters, with growth averaging 56.0% over the last eight quarters.
- Over the past five years, the year-over-year growth in Research & Development ranged from 11.8% (Q4 2025) to 119.5% (Q1 2024).
- Per Business Quant data, CGON's Research & Development in the three quarters before Q2 2026 was $43.73 million (Q1 2026), $29.96 million (Q4 2025) and $27.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | CG Oncology | 6.15 Bn | 6.15 Bn | -2.77 Mn | 54.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.66 Mn |
| Mar 31, 2026 | 43.73 Mn |
| Dec 31, 2025 | 29.96 Mn |
| Sep 30, 2025 | 27.88 Mn |
| Jun 30, 2025 | 31.33 Mn |
| Mar 31, 2025 | 27.47 Mn |
| Dec 31, 2024 | 26.80 Mn |
| Sep 30, 2024 | 19.62 Mn |
| Jun 30, 2024 | 18.47 Mn |
| Mar 31, 2024 | 17.21 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Sep 30, 2023 | 11.74 Mn |
| Jun 30, 2023 | 9.83 Mn |
| Mar 31, 2023 | 7.84 Mn |
API Access
CG Oncology Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CGON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CGON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CGON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();